Literature DB >> 30309752

A stochastic epigenetic Mendelian oligogenic disease model for type 1 diabetes.

Chester A Alper1, Charles E Larsen2, Michael R Trautwein3, Dennis R Alford3.   

Abstract

The incidence of type 1 diabetes (T1D) and some other complex diseases is increasing. The cause has been attributed to an undefined changing environment. We examine the role of the environment (or any changing non-genetic mechanism) in causing the rising incidence, and find much evidence against it: 1) Dizygotic twin T1D concordance is the same as siblings of patients in general; 2) If the environment is responsible for both the discordance among identical twins of patients with T1D and its rising incidence, the twin concordance rate should be rising, but it is not; 3) Migrants from high-to low-incidence countries continue to have high-incidence children; 4) TID incidence among the offspring of two T1D parents is identical to the monozygotic twin rate. On the other hand, genetic association studies of T1D have revealed strong susceptibility in the major histocompatibility complex and many optional additive genes of small effect throughout the human genome increasing T1D risk. We have, from an analysis of previously published family studies, developed a stochastic epigenetic Mendelian oligogenic (SEMO) model consistent with published observations. The model posits a few required recessive causal genes with incomplete penetrance explaining virtually all of the puzzling features of T1D, including its rising incidence and the specific low T1D incidence rates among first-degree relatives of patients. Since historic selection against any causal gene could prevent T1D, we postulate that the rising incidence is because of increasing population mixing of parents from some previously isolated populations that had selected against different causal genes.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Disease association; Epigenetics; Genetics; HLA; Monozygotic twins; Type 1 diabetes

Year:  2018        PMID: 30309752      PMCID: PMC6326579          DOI: 10.1016/j.jaut.2018.09.006

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  90 in total

1.  The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study.

Authors:  Jeffrey P Krischer; Kristian F Lynch; Desmond A Schatz; Jorma Ilonen; Åke Lernmark; William A Hagopian; Marian J Rewers; Jin-Xiong She; Olli G Simell; Jorma Toppari; Anette-G Ziegler; Beena Akolkar; Ezio Bonifacio
Journal:  Diabetologia       Date:  2015-02-10       Impact factor: 10.122

2.  Geographical differences within Finland in the frequency of HLA-DQ genotypes associated with type 1 diabetes susceptibility. The Childhood Diabetes in Finland Study Group.

Authors:  J Ilonen; H Reijonen; A Green; A Reunanen; M Knip; O Simell; H K Akerblom
Journal:  Eur J Immunogenet       Date:  2000-08

3.  Regional differences in the incidence of insulin-dependent diabetes mellitus among children in Finland from 1987 to 1991. Childhood Diabetes in Finland (DiMe) Study Group.

Authors:  M Karvonen; J Rusanen; M Sundberg; E Virtala; A Colpaert; A Naukkarinen; J Tuomilehto
Journal:  Ann Med       Date:  1997-08       Impact factor: 4.709

4.  Extended major histocompatibility complex haplotypes in type I diabetes mellitus.

Authors:  D Raum; Z Awdeh; E J Yunis; C A Alper; K H Gabbay
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

Review 5.  Diabetes in Japan: a review of disease burden and approaches to treatment.

Authors:  Susan E Neville; Kristina S Boye; William S Montgomery; Kazuya Iwamoto; Masato Okamura; Risa P Hayes
Journal:  Diabetes Metab Res Rev       Date:  2009-11       Impact factor: 4.876

6.  Extended HLA/complement allele haplotypes: evidence for T/t-like complex in man.

Authors:  Z L Awdeh; D Raum; E J Yunis; C A Alper
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

7.  Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children.

Authors:  Anette G Ziegler; Marian Rewers; Olli Simell; Tuula Simell; Johanna Lempainen; Andrea Steck; Christiane Winkler; Jorma Ilonen; Riitta Veijola; Mikael Knip; Ezio Bonifacio; George S Eisenbarth
Journal:  JAMA       Date:  2013-06-19       Impact factor: 56.272

8.  Additive and interaction effects at three amino acid positions in HLA-DQ and HLA-DR molecules drive type 1 diabetes risk.

Authors:  Xinli Hu; Aaron J Deutsch; Tobias L Lenz; Suna Onengut-Gumuscu; Buhm Han; Wei-Min Chen; Joanna M M Howson; John A Todd; Paul I W de Bakker; Stephen S Rich; Soumya Raychaudhuri
Journal:  Nat Genet       Date:  2015-07-13       Impact factor: 38.330

9.  Dominant sequences of human major histocompatibility complex conserved extended haplotypes from HLA-DQA2 to DAXX.

Authors:  Charles E Larsen; Dennis R Alford; Michael R Trautwein; Yanoh K Jalloh; Jennifer L Tarnacki; Sushruta K Kunnenkeri; Dolores A Fici; Edmond J Yunis; Zuheir L Awdeh; Chester A Alper
Journal:  PLoS Genet       Date:  2014-10-09       Impact factor: 5.917

10.  Increasing incidence of type 1 diabetes in youth: twenty years of the Philadelphia Pediatric Diabetes Registry.

Authors:  Terri H Lipman; Lorraine E Levitt Katz; Sarah J Ratcliffe; Kathryn M Murphy; Alexandra Aguilar; Iraj Rezvani; Carol J Howe; Shruti Fadia; Elizabeth Suarez
Journal:  Diabetes Care       Date:  2013-01-22       Impact factor: 19.112

View more
  2 in total

1.  Segregation Analysis of Genotyped and Family-Phased, Long Range MHC Classical Class I and Class II Haplotypes in 5 Families With Type 1 Diabetes Proband in the United Arab Emirates.

Authors:  Guan K Tay; Halima Al Naqbi; Aurélie Mawart; Zahrah Baalfaqih; Anoud Almaazmi; Asma Deeb; Habiba Alsafar
Journal:  Front Genet       Date:  2021-06-30       Impact factor: 4.599

2.  A New Pedigree-Based SNP Haplotype Method for Genomic Polymorphism and Genetic Studies.

Authors:  Zareen Vadva; Charles E Larsen; Bennett E Propp; Michael R Trautwein; Dennis R Alford; Chester A Alper
Journal:  Cells       Date:  2019-08-05       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.